These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26401658)

  • 1. African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.
    Krotneva SP; Coffeng LE; Noma M; Zouré HG; Bakoné L; Amazigo UV; de Vlas SJ; Stolk WA
    PLoS Negl Trop Dis; 2015; 9(9):e0004051. PubMed ID: 26401658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact.
    Mohammed KA; Deb RM; Stanton MC; Molyneux DH
    Parasit Vectors; 2012 Dec; 5():299. PubMed ID: 23259465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population.
    Heukelbach J; Winter B; Wilcke T; Muehlen M; Albrecht S; de Oliveira FA; Kerr-Pontes LR; Liesenfeld O; Feldmeier H
    Bull World Health Organ; 2004 Aug; 82(8):563-71. PubMed ID: 15375445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
    Coffeng LE; Stolk WA; Zouré HG; Veerman JL; Agblewonu KB; Murdoch ME; Noma M; Fobi G; Richardus JH; Bundy DA; Habbema D; de Vlas SJ; Amazigo UV
    PLoS Negl Trop Dis; 2013; 7(1):e2032. PubMed ID: 23383355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities to investigate the effects of ivermectin mass drug administration on scabies.
    Engelman D; Martin DL; Hay RJ; Chosidow O; McCarthy JS; Fuller LC; Steer AC
    Parasit Vectors; 2013 Apr; 6():106. PubMed ID: 23594459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection.
    Vieira JC; Cooper PJ; Lovato R; Mancero T; Rivera J; Proaño R; López AA; Guderian RH; Guzmán JR
    BMC Med; 2007 May; 5():9. PubMed ID: 17521449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
    Vinkeles Melchers NVS; Stolk WA; van Loon W; Pedrique B; Bakker R; Murdoch ME; de Vlas SJ; Coffeng LE
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009604. PubMed ID: 34310602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis.
    Olsen A
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):747-58. PubMed ID: 17481681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
    Coffeng LE; Stolk WA; Hoerauf A; Habbema D; Bakker R; Hopkins AD; de Vlas SJ
    PLoS One; 2014; 9(12):e115886. PubMed ID: 25545677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The African Programme for Onchocerciasis Control (APOC).
    Amazigo U
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():19-22. PubMed ID: 18718149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: The Ivermectin African Enigma.
    Guerrero R; Bravo LE; Muñoz E; Ardila EKG; Guerrero E
    Colomb Med (Cali); 2020 Dec; 51(4):e2014613. PubMed ID: 33795896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
    Anselmi M; Buonfrate D; Guevara Espinoza A; Prandi R; Marquez M; Gobbo M; Montresor A; Albonico M; Racines Orbe M; Martin Moreira J; Bisoffi Z
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004150. PubMed ID: 26540412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria.
    Brieger WR; Okeibunor JC; Abiose AO; Wanji S; Elhassan E; Ndyomugyenyi R; Amazigo UV
    Parasit Vectors; 2011 Jul; 4():152. PubMed ID: 21794139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mectizan Donation Program (MDP).
    Thylefors B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.
    Noma M; Zouré HG; Tekle AH; Enyong PA; Nwoke BE; Remme JH
    Parasit Vectors; 2014 Jul; 7():325. PubMed ID: 25053266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indication of Mectizan in human medicine other than onchocerciasis].
    Richard-Lenoble D
    Sante; 1998; 8(1):84-7. PubMed ID: 9592892
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
    Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
    Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ivermectin on illness and disability associated with onchocerciasis.
    Tielsch JM; Beeche A
    Trop Med Int Health; 2004 Apr; 9(4):A45-56. PubMed ID: 15078278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
    Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
    Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.